Posted in | News | Display | Medical Optics

Dong In Optical Introduces New Dot Sight for 40 mm Caliber Automatic Grenade Launcher

Dong In Optical Co., Ltd. a manufacturer of Military Red Dot Sight for various weapons in South Korea, introduced their new Dot Sight for 40 mm Caliber Automatic Grenade Launcher (AGL) named Model DCL401. This latest invention from Dong In Optical is the world's first Dot Sight for Automatic Grenade Launcher and will be distributed to various armed forces markets in Europe and Northern America.

DCL401 is specifically designed and built for 40 mm Caliber Automatic Grenade Launcher (AGL) such as MK19 and K4 AGLs. It improves the AGL operator's shooting ability with outstanding vision and brings his shooting ability to the next level by aiming for both close and long range, non-moving targets, and moving targets such as armored vehicles and tanks. This unique Dot Sight comes together with an exclusive mounting device which provides adjustable bullet drop compensation (trajectory compensator) with 12 different settings.

With this amazing DCL401, even the untrained operator could hit the target utilizing the dot as a rangefinder with the first round of shot. The compensator is designed to be adjustable from 200 m to 1,500 m with 100 m increments. This unique state of the art device is materialized exclusively by Dong In Optical. The Dot Sight from Dong In Optical uses wide lens, which provides a wide field of sight and head-up display for the operator to aim and track down the targets with both eyes open.

Mr. Jung, the CEO of Dong In Optical Co., Ltd. said, "Model DCL401 has already passed various tests at a local military field and drawn eulogies and admiration from the concerned military authorities. Despite of short period of promotion and introduction time, we are already involved in export discussion with a number of countries around the world."

For more information about Dong In Optical Co., Ltd. please visit www.donginoptical.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.